Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified
Crossref DOI link: https://doi.org/10.1007/s00277-016-2877-6
Published Online: 2016-11-17
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qi, Fei
Dong, Mei
He, Xiaohui
Li, Yexiong
Wang, Weihu
Liu, Peng
Yang, Jianliang
Gui, Lin
Zhang, Changgong
Yang, Sheng
Zhou, Shengyu
Shi, Yuankai
License valid from 2016-11-17